期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

胰腺恶性肿瘤肝转移综合治疗现状 被引量：4

原文传递
导出
摘要 近年来，胰腺恶性肿瘤在我国的发病率和死亡率呈逐年上升趋势。依照不同的病理学类型，胰腺恶性肿瘤可分为胰腺癌和胰腺神经内分泌癌。胰腺神经内分泌癌是一类极少见的胰腺恶性肿瘤，其恶性程度相对较低，生长缓慢。据统计，每年发病率约1／10万，
作者 李泽朝 罗诗樵
机构地区 重庆医科大学附属第一医院肝胆外科
出处 《中国实用外科杂志》 CSCD 北大核心 2014年第3期270-272,共3页 Chinese Journal of Practical Surgery
关键词 胰腺恶性肿瘤 神经内分泌癌 胰腺癌 肝转移 pancreatic neoplasm neuroendocrine carcinoma pancreatic ductal carcinoma liver metastases
分类号 R6 [医药卫生—外科学]
  • 相关文献

参考文献8

二级参考文献56

  • 1李卉,曾蒙苏,周康荣,陈刚,缪熙音,张利军,陆秀良,刘豪,陆怡,殷允娟.胰腺癌侵犯胰周主要血管的CT表现分析[J].中华放射学杂志,2005,39(3):293-297. 被引量：36
  • 2刘凌晓,王建华,王小林,颜志平,刘嵘,陈颐,周大勇.中晚期胰腺癌动脉灌注吉西他滨化疗的疗效分析[J].中国医学计算机成像杂志,2007,13(3):202-207. 被引量：15
  • 3JL Van Laethem, M Polus, R Marechal. Gerncitabine and oxalip latine (GEMOX) in gemcitabine - refractory advanced pancreatic cancer: A phase Ⅱ study. Proc ASCO,2004,23:4119A.
  • 4孙燕,石远凯.临床肿瘤内科手册(第5版)[M].北京:人民卫生出版社,2009:80-82;76-78.
  • 5Guo X,Cui Z.Current diagnosis and treatment of pancreatic cancer in China[J].Pancreas,2005,31(1):13-22.
  • 6Thomson BN,Banting SW,Gibbs P.Pancreatic cancer-current management[J].Aust Fam Physician,2006,35(4):212-217.
  • 7National Comprehensive Cancer Network.Clinical practice guidelines in oncology:pancreatic cancer[R/OL].[2009-04-28].http://www.nccn.org.
  • 8Saif MW.New developments in the treatment of pancreatic cancer[J].JOP,2008,9(4):391-397.
  • 9De Jong MC,Farnell MB,Sclabas G,et al.Liver-directed therapy for hepatic metastases in patients undergoing pancreaticoduodenectomy:a dual-center analysis[J].Ann Surg,2010,252(1):142-148.
  • 10Vogl TJ,Zangos S,Eichler K,et al.Palliative hepatic intraarterial chemotherapy (HIC) using a novel combination of gemcitabine and mitomycin C:results in hepatic metastases[J].Eur Radiol,2008,18(3):468-476.

共引文献57

同被引文献23

  • 1Cannistr/t M, Ruggiero M, Zullo A, et al. Metastases of pancreatic adenocarcinoma: A systematic review of literature and a new functional concept. Int 1 Sure, 2015, 6(26): 873-876.
  • 2Tafuto S, von Arx C, De Divitiis C, et al. Electrochemotherapy as a new approach on pancreatic cancer and on liver metastases. Int J Surg, 2015, 6(27): 382-385.
  • 3Ray K. Pancreatic cancer: Pancreatic cancer exosomes prime theliver for metastasis. Nat Rev Gastroenterol Hepatol, 2015, 12(7): 371-375.
  • 4Costa-Silva B, Aiello NM, Ocean AJ, et al. Pancreatic cancer exosornes initiate pre-metastatic niche formation in the liver. Nat CellBiol, 2015, 17(6): 816-826.
  • 5Peixoto RD, Speers C, McGahan CE, et al. Prognostic factors and sites of metastasis in unresectable locally advanced pancreatic cancer. CancerMed, 2015, 4(18): 1028-1033.
  • 6Han Y, Ru GQ, Mou X, et al. AUTS2 is a potential therapeutic target for pancreatic cancer patients with liver metastases. Med Hypotheses, 2015, 3(1): 920-923.
  • 7Nakayama A1, Tajima H, Kitagawa H, et al. A case report of hepatic arterial infusion chemotherapy and RFA for liver metastasis from pancreatic cancer. Gan To Kagaku Ryoho, 2014, 41(12): 2205-2207.
  • 8Kawamoto T, Hishima T, Kimura K, et al. Calcified liver metastases from a non-functioning pancreatic neuroendocrine tumor. Clin J Gastroenterol, 201, 7(5): 460-464.
  • 9Bolm L, lanssen S, Kismann L, et al. Predicting survival after irradiation of metastases from pancreatic cancer. Anticancer Res, 2015, 35(7): 4105-4108.
  • 10Cannistr~ M, Ruggiero M, Zullo A, et al. Metastases of pancreatic adenocarcinoma: a systematic review of literature and a new functional concept. Int J Surg, 2015, 6(26):873-876.

引证文献4

二级引证文献1

中国实用外科杂志
2014年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部